Prestige Consumer Healthcare (PBH) Debt to Equity (2011 - 2024)
Prestige Consumer Healthcare (PBH) recorded quarterly Debt to Equity of $0.68 in Q1 2024, down 26.86% quarter-over-quarter from $0.93 in Q1 2023, and down 26.86% on a YoY basis from $0.93 in Q2 2023.
Prestige Consumer Healthcare (PBH) Debt to Equity (2011 - 2024) Analysis & Trends
Prestige Consumer Healthcare's Debt to Equity history runs 14 years deep, the most recent figure standing at $0.68 for Q1 2024.
- In Q1 2024, Debt to Equity fell 26.86% year-over-year to $0.68; the TTM figure through Mar 2024 stood at $0.68 (down 26.86% YoY), while the FY2024 annual figure was $0.68, down 26.86% from the prior year.
- Debt to Equity was $0.68 for Q1 2024 at Prestige Consumer Healthcare, down from $0.93 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.48 in Q1 2020 to a low of $0.0 in Q3 2021.
- Historically, Debt to Equity has averaged $0.99 across 5 years, with a median of $1.09 in 2021.
- The sharpest annual moves came in 2021 and 2023: Debt to Equity slumped 99.66% in 2021, then retreated 0.64% in 2023.
- A 5-year view of Debt to Equity shows it stood at $1.17 in 2020, then sank by 99.65% to $0.0 in 2021, then jumped by 22701.91% to $0.94 in 2022, then retreated by 0.64% to $0.93 in 2023, then retreated by 26.86% to $0.68 in 2024.
- The last three Debt to Equity figures came in at $0.68 (Q1 2024), $0.93 (Q1 2023), and $0.94 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.68 |
| Mar 31, 2023 | 0.93 |
| Mar 31, 2022 | 0.94 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 1.09 |
| Mar 31, 2021 | 1.09 |
| Dec 31, 2020 | 1.17 |
| Sep 30, 2020 | 1.21 |
| Jun 30, 2020 | 1.32 |
| Mar 31, 2020 | 1.48 |
| Dec 31, 2019 | 1.47 |
| Sep 30, 2019 | 1.58 |
| Jun 30, 2019 | 1.62 |
| Mar 31, 2019 | 1.64 |
| Dec 31, 2018 | 1.49 |
| Sep 30, 2018 | 1.59 |
| Jun 30, 2018 | 1.72 |
| Mar 31, 2018 | 1.69 |
| Dec 31, 2017 | 1.69 |
| Sep 30, 2017 | 2.34 |